In the context of the ART-mediated mechanism in cancer cells, it was shown earlier that high activity of Nrf2 (and thus high expression of HO-1) correlated with resistance against ART, and sensitivity to ART was increased upon the inhibition of Nrf2 [54,68]. The gene discussed is HMOX1; the disease is cancer.